论文信息 - 1180 RITONAVIR SUBSTANTIALLY REDUCES REACTIVE METABOLITE FORMATION OF THE HCV PROTEASE INHIBITOR DANOPREVIR BOTH IN VITRO AND IN VIVO - 字舞流文

1180 RITONAVIR SUBSTANTIALLY REDUCES REACTIVE METABOLITE FORMATION OF THE HCV PROTEASE INHIBITOR DANOPREVIR BOTH IN VITRO AND IN VIVO

T. Singer | P. Goelzer | P. N. Morcos | Patrick F. Smith | B. Brennan | N. Shulman | J. Q. Tran | J. Hammond | B. Wen